(Q39491165)

12 September 2017

title

The interleukin 6 receptor is a direct transcriptional target of E2F3 in prostate tumor derived cells (English)

1 reference

12 September 2017

0 references

1 reference

Stephen J Libertini

1

1 reference

12 September 2017

Honglin Chen

2

1 reference

12 September 2017

Bushra al-Bataina

3

1 reference

12 September 2017

Tilak Koilvaram

4

1 reference

12 September 2017

Michael George

5

1 reference

12 September 2017

Allen C Gao

6

1 reference

12 September 2017

Maria Mudryj

7

1 reference

12 September 2017

publication date

11 August 2011

1 reference

12 September 2017

1 reference

12 September 2017

volume

72

1 reference

12 September 2017

issue

6

1 reference

12 September 2017

page(s)

649-660

1 reference

12 September 2017

cites work

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

The Rb/E2F pathway and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

The E2F6 transcription factor is a component of the mammalian Bmi1-containing polycomb complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

Synergistic function of E2F7 and E2F8 is essential for cell survival and embryonic development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

Complex transcriptional regulatory mechanisms control expression of the E2F3 locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

E2f3a and E2f3b make overlapping but different contributions to total E2f3 activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

Expression analysis of 6p22 genomic gain in retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

Amplification and overexpression of E2F3 in human bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

Non-Small-Cell Lung Cancer Molecular Signatures Recapitulate Lung Developmental Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

Role of E2F3 expression in modulating cellular proliferation rate in human bladder and prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

E2F3a stimulates proliferation, p53-independent apoptosis and carcinogenesis in a transgenic mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

E2F1 is crucial for E2F-dependent apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

Gene expression phenotypic models that predict the activity of oncogenic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

Compensation and specificity of function within the E2F family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

The E2F3-Oncomir-1 axis is activated in Wilms' tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

Interleukin-6: structure-function relationships.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

IL-6 signal transduction and its physiological roles: the signal orchestration model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

Molecular mechanisms of castration-resistant prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

Cytokine disbalance in common human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

Use of chromatin immunoprecipitation to clone novel E2F target promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

The role of calpain in the proteolytic cleavage of E-cadherin in prostate and mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

Id-1 and Id-2 proteins as molecular markers for human prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

A comprehensive ChIP-chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals interchangeable roles of E2F family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

Identification of Aurora-A as a direct target of E2F3 during G2/M cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

Regulation of the cyclin E gene by transcription factor E2F1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

Anti-interleukin-6 monoclonal antibody induces regression of human prostate cancer xenografts in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

Clinical and correlative results of SWOG S0354: a phase II trial of CNTO328 (siltuximab), a monoclonal antibody against interleukin-6, in chemotherapy-pretreated patients with castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21468

21 January 2018

Identifiers

DOI

10.1002/PROS.21468

1 reference

12 September 2017

1 reference